Immune-Smart Biomaterials Could Revolutionize Muscle Repair After Severe Injury

Severe skeletal muscle injuries—from trauma, disease, or aging—present a major clinical challenge because they disrupt not just muscle fibers but also the blood vessels and nerves essential for function. Unlike minor injuries that heal naturally, severe damage triggers chronic inflammation that prevents proper repair and leads to permanent disability.

This review analyzes emerging biomaterial strategies that work with the immune system rather than against it. The authors examine how different immune cells contribute to muscle repair: neutrophils clear debris early on, while macrophages transition from inflammatory to healing modes, and regulatory T cells help resolve inflammation. When this process goes wrong, chronic inflammation destroys tissue and prevents regeneration.

Promising biomaterial approaches include scaffolds that deliver targeted anti-inflammatory drugs, materials that recruit beneficial immune cells like M2 macrophages, and engineered surfaces that promote nerve and blood vessel regrowth. Some materials use natural inflammatory responses to synthetic polymers as therapeutic tools, while others incorporate growth factors that coordinate repair across multiple tissue types.

The clinical implications are significant. Current treatments like muscle grafts often fail due to poor integration and limited tissue availability. These immune-modulating biomaterials could restore function after volumetric muscle loss, critical limb ischemia, and degenerative muscle diseases. However, the field faces challenges in translating complex multi-tissue repair strategies from laboratory models to human patients, requiring careful optimization of immune responses across different injury types and patient populations.